Paindrainer, a leader in digital therapeutics, raised more than €800,000 in an oversubscribed share issue to propel the launch of their AI-powered therapeutic monitoring system for chronic pain in the US. Supported by investors like Almi Invest and Tramontane Invest, these funds will not only aid in marketing but also fuel clinical trials and the app's development. CEO Erik Frick expressed excitement about the investment's potential to boost the company’s presence in the critical US healthcare market.
"Having completed a share issue transaction in the current market with support from both existing and new owners feels fantastic. It shows the growing interest in these types of second-generation digital companies..."
"I am excited to join Paindrainer as an engaged shareholder in its journey towards helping chronic pain patients increase their quality of life..."
"We are thrilled to support Paindrainer as they continue their mission to improve chronic pain management. Their patient-centric approach..."
#digital-therapeutics #chronic-pain-management #investment #artificial-intelligence #healthcare-innovation
Collection
[
|
...
]